Zegalogue Autoinjector Uses, Dosage, Side Effects and more
Zegalogue Autoinjector is under investigation in clinical trial NCT03735225 (Evaluation of the Safety, Tolerability and Bioavailability of Zegalogue Autoinjector Following Subcutaneous (SC) Compared to IV Administration).
| Attribute | Details |
|---|---|
| Trade Name | Zegalogue Autoinjector |
| Availability | Prescription only |
| Generic | Dasiglucagon |
| Dasiglucagon Other Names | Dasiglucagon |
| Related Drugs | glucagon, Baqsimi, diazoxide, Gvoke, GlucaGen, Proglycem |
| Weight | 0.6mg/0.6ml, |
| Type | Subcutaneous solution |
| Groups | Approved, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | United States |
| Last Updated: | January 7, 2025 at 1:49 am |
Disease Interaction
Major: insulinoma, pheochromocytomaModerate: glycogen depletion
